Articles

CLINICAL RESEARCH

10.4244/EIJ-D-17-00796 Aug 3, 2018
Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial
Xu B, Yang Y, Han Y, Huo Y, Wang L, Qi X, Li J, Chen Y, Kuo H-C, Ying S, Cheong W-F, Zhang Y, Su X, Popma J, Gao R, Stone GW
free

CLINICAL RESEARCH

10.4244/EIJ-D-18-00392 Aug 3, 2018
Bioabsorbable polymer everolimus-eluting stents in patients with acute myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry
Buccheri S, Sarno G, Lagerqvist B, Olivecrona G, Hambraeus K, Witt N, Lindholm D, Erlinge D, Angerås O, James S
free

CLINICAL RESEARCH

10.4244/EIJ-D-17-00461 Aug 3, 2018
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy
Asano T, Katagiri Y, Collet C, Tenekecioglu E, Miyazaki Y, Sotomi Y, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernández-Antolín R, van de Harst P, Iñiguez A, Janssens L, Smits PC, Wykrzykowska JJ, Ribeiro V, Pereira H, da Silva P, Piek J, Reiber JH, von Birgelen C, Sabaté M, Onuma Y, Serruys PW
free

CLINICAL RESEARCH

10.4244/EIJ-D-18-00131 Aug 3, 2018
Impact of bleeding assessment and adjudication methodology on event rates and clinical trial outcomes: insights from the HORIZONS-AMI trial
Kosmidou I, Mintz GS, Jatene T, Embacher M, Redfors B, Wong SC, Dressler O, Mehran R, Ben-Yehuda O, Jenkins PL, Stone GW
free

CLINICAL RESEARCH

10.4244/EIJ-D-18-00344 Aug 3, 2018
Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry
Landmesser U, Tondo C, Camm J, Diener H, Paul V, Schmidt B, Settergren M, Teiger E, Nielsen-Kudsk J, Hildick-Smith D
free

10.4244/EIJY18M07_1 Aug 3, 2018
Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medications
Ewen S, Lauder L, Azizi M, Kandzari D, Pathak A, Sharif F, Wijns W, Mahfoud F, Lüscher T
free

10.4244/EIJY18M07_2 Aug 3, 2018
Will SPYRAL HTN-OFF MED change my practice? SPYRAL HTN-OFF MED: a prospective, randomised, sham-controlled trial on renal denervation in the absence of antihypertensive medications
Lauder L, Ewen S, Azizi M, Mauri L, Lurz P, Lobo M, Sharif F, Wijns W, Tsioufis C, Mahfoud F
free

10.4244/EIJV14I4A63 Jul 20, 2018
To unsubscribe, please click here
Capodanno D
free

10.4244/EIJV14I4A67 Jul 20, 2018
TAVI durability beyond five years: no alarms, but stay alert
Eltchaninoff H, Durand E, Cribier A
free

10.4244/EIJV14I4A69 Jul 20, 2018
What is new in the armamentarium of coronary surgeons to compete with PCI?
Gaudino M, Taggart D
free
Receive our newsletter


PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved